Interpretation of Antibacterial Susceptibility Reports: In Vitro versus Clinical Break-Points

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.2, 2001-01, pp. : 163-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Susceptibility of the Mycobacterium Genus: In Vitro Tests and Clinical Implications

Current Clinical Pharmacology, Vol. 1, Iss. 3, 2006-09 ,pp. : 277-289

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Drug Interactions via Mechanism-Based Cytochrome P450 Inactivation: Points to Consider for Risk Assessment from In Vitro Data and Clinical Pharmacologic Evaluation

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 449-462

Bentham Science Publishers

Access to resources Recommend Favorite

PDE-5 Inhibitors: Clinical Points

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 420-426

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical pharmacokinetics: brief reports

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 22, Iss. 4, 2006-04 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite